Cerapedics Inc.

Stories

Medicare adds PearlMatrix bone graft to new-technology payment program

Developer and marketer of PearlMatrix and i-FACTOR bone grafts

Hospitals that use PearlMatrix for lumbar fusion can now claim part of its extra cost back from Medicare. The payment took effect October 1, 2026, and for the first year the maximum add-on is $3,380 per case.

Updated Oct 20

The long road to FDA approval for spinal biologics

New Capabilities

As of May 2026: Competitor with FDA-approved PearlMatrix P-15 bone graft

Medtronic's INFUSE bone graft has spent 24 years navigating FDA approval, off-label controversy, and lawsuits. The FDA just approved INFUSE for transforaminal lumbar interbody fusion (TLIF) procedures—the only growth factor bone graft approved for two-level spinal constructs and the only one cleared for anterior, oblique, and transforaminal approaches.

Updated May 29